Section Arrow
KRYS.NASDAQ
- Krystal Biotech
Quotes are at least 15-min delayed:2026/07/12 03:08 EDT
Regular Hours
Last
 365.81
-5.43 (-1.46%)
Day High 
375 
Prev. Close
371.24 
1-M High
382.535 
Volume 
363.58K 
Bid
355.7
Ask
365.9
Day Low
355.55 
Open
375 
1-M Low
309.45 
Market Cap 
10.94B 
Currency 美元 
P/E 49.7 
%Yield -- 
10-SMA 371.86 
20-SMA 351.98 
50-SMA 319.03 
52-W High 382.535 
52-W Low 130.5002 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
7.47/10.02
Enterprise Value
10.95B
Balance Sheet
Book Value Per Share
43.31
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
389.13M
Operating Revenue Per Share
0.29
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ELABPmgc Holdings Inc1.12+0.06+5.66%-- 
RXRXRecursion Pharmaceuticals3.56-0.2-5.32%-- 
VYNEVYNE Therapeutics0.6376-0.0344-5.12%-- 
HUMAHumacyte0.6937-0.0066-0.94%-- 
GOSSGossamer Bio0.1697-0.0053-3.03%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company usesits patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates asone operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.